# A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body

> **NCT06655220** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Metformin hydrochloride
- **DRUG:** BI 1815368

## Key facts

- **NCT ID:** NCT06655220
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-08
- **Primary completion:** 2024-12-08
- **Final completion:** 2025-01-13
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655220, "A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06655220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*